These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 15706463)
21. Functional characterization of the nonpeptide neurokinin3 (NK3) receptor antagonist, SR142801 on the human NK3 receptor expressed in Chinese hamster ovary cells. Oury-Donat F; Carayon P; Thurneyssen O; Pailhon V; Emonds-Alt X; Soubrié P; Le Fur G J Pharmacol Exp Ther; 1995 Jul; 274(1):148-54. PubMed ID: 7616392 [TBL] [Abstract][Full Text] [Related]
22. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone. Demiralay C; Jahn H; Kellner M; Yassouridis A; Wiedemann K World J Biol Psychiatry; 2012 Oct; 13(7):526-34. PubMed ID: 22111662 [TBL] [Abstract][Full Text] [Related]
23. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder. Kellner M; Wiedemann K; Yassouridis A; Levengood R; Guo LS; Holsboer F; Yehuda R Biol Psychiatry; 2000 Jan; 47(2):107-11. PubMed ID: 10664826 [TBL] [Abstract][Full Text] [Related]
24. Effects of cholecystokinin tetrapeptide on respiratory function in healthy volunteers. Bradwejn J; LeGrand JM; Koszycki D; Bates JH; Bourin M Am J Psychiatry; 1998 Feb; 155(2):280-2. PubMed ID: 9464212 [TBL] [Abstract][Full Text] [Related]
25. Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males. Goettel M; Fuertig R; Mack SR; Just S; Sharma V; Wunder A; den Boer J CNS Drugs; 2023 Dec; 37(12):1099-1109. PubMed ID: 38019356 [TBL] [Abstract][Full Text] [Related]
26. Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder. Bradwejn J; Koszycki D; Meterissian G Can J Psychiatry; 1990 Feb; 35(1):83-5. PubMed ID: 2180549 [TBL] [Abstract][Full Text] [Related]
27. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Bradwejn J; Koszycki D; Shriqui C Arch Gen Psychiatry; 1991 Jul; 48(7):603-10. PubMed ID: 2069490 [TBL] [Abstract][Full Text] [Related]
28. Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers. Bradwejn J; Koszycki D; Paradis M; Reece P; Hinton J; Sedman A Biol Psychiatry; 1995 Dec; 38(11):742-6. PubMed ID: 8580227 [TBL] [Abstract][Full Text] [Related]
29. Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings. Bradwejn J; Koszycki D; Payeur R; Bourin M; Borthwick H Am J Psychiatry; 1992 Jul; 149(7):962-4. PubMed ID: 1609879 [TBL] [Abstract][Full Text] [Related]